FRX Forest Road Acquisition Corp

NEW YORK, Aug. 13 /PRNewswire-FirstCall/ -- Forest Laboratories, Inc. (NYSE:FRX) announced today that its Board of Directors has authorized an increase to the Company's share repurchase program to 35 million shares of its common stock. The share repurchase program, announced on May 18, 2006, initially authorized 25 million shares of common stock. To date, the Company has repurchased approximately 16.3 million shares under the program, which has no set expiration date. The Company expects to make additional repurchases, from time to time in the open market, depending upon market conditions. (Logo: http://www.newscom.com/cgi-bin/prnh/20001011/FORESTLOGO ) Except for the historical information contained herein, this release contains "forward-looking statements" within the meaning of the Private Securities Reform Act of 1995. These statements involve a number of risks and uncertainties, including the difficulty of predicting FDA approvals, acceptance and demand for new pharmaceutical products, the impact of competitive products and pricing, the timely development and launch of new products and the risk factors listed from time to time in the Company's SEC reports, including the Company's Annual Report on Form 10-K for the fiscal year ended March 31, 2007 and Quarterly Report on form 10-Q for he period ended June 30, 2007. http://www.newscom.com/cgi-bin/prnh/20001011/FORESTLOGO http://photoarchive.ap.org/ DATASOURCE: Forest Laboratories, Inc. CONTACT: Charles E. Triano, Vice President - Investor Relations of Forest Laboratories, Inc., +1-212-224-6714, Web site: http://www.frx.com/

Copyright